GGrantIndex
← Search

Targeting Complement 5a-Mediated Immunoregulation for Neurofibroma Therapy

$391,227R33FY2022NSNIH

Cincinnati Childrens Hosp Med Ctr, Cincinnati OH

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →
Targeting Complement 5a-Mediated Immunoregulation for Neurofibroma Therapy · GrantIndex